Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 3, 2008, Pages 635-637

  Sandovsky Losica, H ^a   Shwartzman, R ^a   Lahat, Y ^a   Segal, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antifungal combinations; In vitro activity

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; NIKKOMYCIN Z; NITROGEN; PHOSPHATE BUFFERED SALINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENTIATION; FUNGAL STRAIN; FUNGUS GROWTH; IN VITRO STUDY; INCUBATION TIME; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMINOGLYCOSIDES; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG SYNERGISM; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 49649115341     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn216     Document Type: Letter

References (6)

1. Metcalf SC, Dockrell DH. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts. J Infect 2007; 55: 287-99.
2. Saag MS, Graybill RJ, Larsen RA et al. Practice guidelines for management of cryptococcal disease. Clin Infect Dis 2000; 30 710-8.
3. Sable CA, Strohmaier KM, Chodakewitz JA. Advances in antifungal therapy. Annu Rev Med 2008; 59: 455-73.
4. Baddley JW, Pappas PG. Antifungal combination therapy. Drugs 2005; 65: 1461-80.
5. Sionov E, Mendlovic S, Segal E. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis. J Infect 2006; 53: 131-9.
6. Mukherjee PK, Sheehan DJ, Hitchcock CA et al. Combination treatment of invasive fungal infections. Clin Microbiol Rev 2005; 18: 163-94.